What smart money is saying about Ligand Pharmaceuticals, Inc.
LGND
No fund has written a full thesis on Ligand Pharmaceuticals, Inc. in our archive, but 2 fund letters report a position in it — most recently Buffalo funds Small Cap Growth Fund in June 2026.
Get an email when a fund writes about it
2
Reported positions
0
Bought
0
Sold
2
Letters
Position history
Between Q1 2026 and Q2 2026, 2 fund letters reported a position in Ligand Pharmaceuticals, Inc., with no move described.
| Quarter | Letters | Bought | Sold | Theses |
|---|---|---|---|---|
| Q2 2026 | 1 | 0 | 0 | 0 |
| Q1 2026 | 1 | 0 | 0 | 0 |
Fund activity · 2 positions
- June 2026
“FUND MANAGEMENT TOP 10 HOLDINGS (%)* Silicon Laboratories, Inc. 3.34 WisdomTree, Inc. 3.15 Ligand Pharmaceuticals, Inc. 3.10 JBT Marel Corp 2.48 MYR Group, Inc.”
Ligand Pharmaceuticals, Inc. - March 2026
“FUND MANAGEMENT TOP 10 HOLDINGS (%)* Option Care Health, Inc. 2.80 Ligand Pharmaceuticals, Inc. 2.54 JBT Marel Corporation”
Ligand Pharmaceuticals, Inc.
Read the letters behind these Ligand Pharmaceuticals, Inc. positions
Every quote above comes from a fund letter in our archive. Get unlimited access to the letters themselves — and to Warren AI, which reads all of them for you.
View plans→Share this ledger